MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1590/s0066-782x2010005000140

Медицинская библиотека · Arquivos brasileiros de cardiologia · 2010

Warfarin or aspirin in embolism prevention in patients with mitral valvulopathy and atrial fibrillation.

Lavitola Paulo de Lara, Sampaio Roney Orismar, Oliveira Walter Amorim de, Bôer Berta Napchan, Tarasoutchi Flavio, Spina Guilherme Sobreira, Grinberg Max

СтатьяРандомизированное исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

Atrial fibrillation (AF) associated to rheumatic mitral valve disease (RMVD) increases the incidence of thromboembolism (TE), with warfarin being the standard therapy, in spite of difficulties in treatment adherence and therapeutic control.

OBJECTIVE

To compare the effectiveness of Aspirin vs Warfarin in TE prevention in patients with AF and RMVD.

METHODS

A total of 229 patients (pts) with AF and RMVD were followed in a prospective and randomized study. The first group consisted of 110 pts receiving Aspirin - 200 mg/day (Group Aspirin - GA) and the second group consisted of 119 pts receiving Warfarin at individually-adjusted doses (Group Warfarin - GW).

RESULTS

There were 15 embolic events in GA and 24 in GW (p = 0.187), of which 21 presented INR < 2.0. Thus, after excluding patients with inadequate INR, there was a higher number of embolic events in GA than in GW (15 vs 3) (p < 0.0061). The GW showed lower treatment adherence (p = 0.001). Neither group presented episodes of major bleeding. Small bleeding episodes were more frequent in the GW (p < 0.01). Increased serum levels of cholesterol and triglycerides constituted a risk factor for a higher number of thromboembolic events in the studied population, with no difference between the groups.

CONCLUSION

In patients presenting RMVD with AF for less than a year and no previous embolism, Aspirin is little effective in preventing TE. Patients with lower-risk mitral valvulopathy (mitral regurgitation and mitral biological prosthesis), especially in cases presenting contraindication to or low adherence to Warfarin, Aspirin use can present some benefit in TE prevention.

Для цитирования: Lavitola Paulo de Lara, Sampaio Roney Orismar, Oliveira Walter Amorim de, Bôer Berta Napchan, Tarasoutchi Flavio, Spina Guilherme Sobreira, Grinberg Max. Warfarin or aspirin in embolism prevention in patients with mitral valvulopathy and atrial fibrillation.. Arquivos brasileiros de cardiologia. 2010. DOI: 10.1590/s0066-782x2010005000140.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.